G
Discover Games
Game News

Propranolol Extended Release Capsules Recalled Due to Potential Metal Contamination

G
Discover Games
2026/11/18
1 reads
Propranolol Extended Release Capsules Recalled Due to Potential Metal Contamination

Breckenridge Pharmaceutical, Inc. has issued a voluntary nationwide recall concerning a single lot of 60mg Propranolol Hydrochloride Extended-Release Capsules. The recall is prompted by the potential presence of metal fragments within the medication, which could pose a serious health risk by causing lacerations. This blood pressure medication has been flagged over the possibility of metal contamination, prompting immediate action from both consumers and healthcare providers.

The affected medication is packaged in 100-count bottles and is identified by lot number PK25110035, with an expiration date of May 2029. The pills were distributed to wholesalers and pharmacies across the country during the period spanning from October 26 through November 4. The National Drug Code associated with this specific product is 51991-817-01. This specific recall highlights the critical importance of quality control in pharmaceutical manufacturing, as even trace contaminants can pose a severe danger to patients.

In its official press release, Breckenridge Pharmaceutical stated that the use of product from the affected lot could potentially lead to lacerations of soft tissues. These lacerations could occur in various parts of the digestive system, including the oral cavity, esophagus, stomach, or intestine. The company explained that the affected lot shared intermediate material, which is suspected to be the source of the metal contamination. This contamination was initially identified in a separate lot that had not yet been released to the market, leading to the precautionary recall of the related batch.

Given the potential severity of the contamination, consumers who possess the affected lot are strongly urged to take immediate action. They must immediately stop taking the product and contact their physician or healthcare provider to seek medical advice and replacement instructions. Furthermore, the company advises that any unused portions of the affected product should be returned to the pharmacy where it was originally picked up. This proactive measure helps ensure that the contaminated material is properly handled and removed from circulation.

For professional entities, including wholesalers, pharmacies, and other retail distributors, strict adherence to safety protocols is required. These entities are directed to thoroughly check their current inventory for the recalled lot, quarantine any affected product, and ensure that the affected product is neither distributed nor dispensed to patients. This coordinated effort among industry partners is essential to mitigate the risks associated with the metal fragments and protect public health.

Propranolol capsules are commonly prescribed for a variety of conditions. While they are widely known for treating high blood pressure, they are also utilized in the management of other health issues, such as chest pain, migraines, or tremors. Because of its widespread use in treating chronic conditions, the safety of this medication is paramount, making this recall a significant concern for patients managing these conditions.

While Breckenridge Pharmaceutical has stated that it is not currently aware of any adverse events connected to this specific recall, the company encourages anyone who experiences problems they believe may be related to taking the pills to contact a healthcare provider. These incidents should also be reported through the Food and Drug Administration's MedWatch Adverse Event Reporting program. This vigilance from both consumers and medical professionals is crucial in maintaining the highest standards of pharmaceutical safety.

#drug recall#propranolol#metal contamination#pharmaceutical safety#health warning

Contact Us